GSK Investigational Site

Heidelberg West, Victoria 3084

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Arthritis, Rheumatoid, Diabetes Mellitus, Type 2

Studies at this site

• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) — Stopped early
• A Study In Patients With Type 2 Diabetes Mellitus — Completed
• A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease — Completed
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed